| Product Code: ETC13149187 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Neurology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Neurology Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 North America Neurology Market - Industry Life Cycle |
3.4 North America Neurology Market - Porter's Five Forces |
3.5 North America Neurology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 North America Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Neurology Market Trends |
6 North America Neurology Market, 2021 - 2031 |
6.1 North America Neurology Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Neurology Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.1.3 North America Neurology Market, Revenues & Volume, By Neurovascular Diseases, 2021 - 2031 |
6.1.4 North America Neurology Market, Revenues & Volume, By Neuro-infectious Diseases, 2021 - 2031 |
6.1.5 North America Neurology Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Neurology Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Neurology Market, Revenues & Volume, By Multiple Sclerosis, 2021 - 2031 |
6.2.3 North America Neurology Market, Revenues & Volume, By Epilepsy, 2021 - 2031 |
6.2.4 North America Neurology Market, Revenues & Volume, By Parkinson's Disease, 2021 - 2031 |
6.2.5 North America Neurology Market, Revenues & Volume, By Alzheimer's Disease, 2021 - 2031 |
6.2.6 North America Neurology Market, Revenues & Volume, By Stroke, 2021 - 2031 |
6.2.7 North America Neurology Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Neurology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Neurology Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.3.3 North America Neurology Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.4 North America Neurology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.2 North America Neurology Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Neurology Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Neurology Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.4.5 North America Neurology Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.6 North America Neurology Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neurology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Neurology Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Neurology Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Neurology Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Neurology Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
7.3.1 United States (US) Neurology Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.2 Canada Neurology Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.3 Rest of North America Neurology Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4 North America Neurology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Neurology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Neurology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Neurology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Neurology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Neurology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Neurology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Neurology Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America Neurology Market Key Performance Indicators |
9 North America Neurology Market - Export/Import By Countries Assessment |
10 North America Neurology Market - Opportunity Assessment |
10.1 North America Neurology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Neurology Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.4 North America Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America Neurology Market - Competitive Landscape |
11.1 North America Neurology Market Revenue Share, By Companies, 2022 |
11.2 North America Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here